RxDoctor Payments Data

Atoya Adams

Internal Medicine · Las Vegas, NVNPI 1639127285

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. That places this record below the midpoint for internal medicine clinicians in NV, where the typical reported total is $253.

$82in general payments, 2019–2025

Across 4 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$47
  • Merck$35
$5,401,836in research payments, 2019–2025

Across 386 payments — averaging $13,994 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$4.1M
  • Novartis$989K
  • AbbVie$130K
  • AstraZeneca$63K
  • Gilead$58K
  • Bayer$23K
  • plus $55K from 7 others

What the payments were for

  • Food & beverage$82100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific3$47
Merck1$35

How this compares

$82 in reported general payments places this provider in the 30th percentile of 1,071 internal medicine providers in Nevada.

See all internal medicine providers in Nevada

Other internal medicine in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →